In the science of artificial intelligence (AI), there is a concept called technological singularity. It is the most dangerous level of AI, of technology and indeed, of science itself, for a number of ...
Studying the epic journey of the iconic jumping plumber can lead to new insights in theoretical computer science—and may help ...
Clarkson University researchers have developed a new mathematical tool that could make artificial intelligence systems more ...
Anthropic is urging its rivals to pursue an unprecedented regime of AI arms control. The explosive advances in the company’s ...
Anthropic's research suggests AI is increasingly used to develop and improve new AI systems, with Claude now writing over 80% of code for production. This trend points towards AI systems becoming more ...
Credit: VentureBeat made with OpenAI ChatGPT-Images-2.0 Anthropic co-founder and CEO Dario Amodei said it was coming, but it still feels like a milestone: More than 80% of the code merged into ...
Contrary to their name, bumblebees are no bumbling oafs. A new study published in Science on Thursday found that these bees utilized tools to solve complex problems to win a sugary treat, even if they ...
What separates Cerebras from other AI chipmakers like Nvidia (NVDA 1.41%) is its wafer-scale engine technology. Instead of ...
Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...
Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...
Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...
Najat Khan looks at successful platform companies like Vertex, Regeneron and Alnylam and sees a path for Recursion to join them—if the company stays disciplined. (Recursion Pharmaceuticals) Chris ...